Raymed Labs Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported net loss was INR 0.17 million compared to INR 0.244 million a year ago. Basic loss per share from continuing operations was INR 0.0399 compared to INR 0.0571 a year ago. Diluted loss per share from continuing operations was INR 0.0399 compared to INR 0.0571 a year ago.
For the six months, net loss was INR 0.328 million compared to INR 0.759 million a year ago. Basic loss per share from continuing operations was INR 0.0767 compared to INR 0.1777 a year ago. Diluted loss per share from continuing operations was INR 0.0767 compared to INR 0.1777 a year ago.